Intradermal hepatitis B vaccination: five-year follow-up. 1995

S Leonardi, and P Barone, and S Musumeci
Department of Pediatrics, University of Catania, Italy.

UI MeSH Term Description Entries
D007271 Injections, Intradermal The forcing into the skin of liquid medication, nutrient, or other fluid through a hollow needle, piercing the top skin layer. Intradermal Injections,Injection, Intradermal,Intradermal Injection
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006510 Hepatitis B Antibodies Antibodies to the HEPATITIS B ANTIGENS, including antibodies to the surface (Australia) and core of the Dane particle and those to the "e" antigens. Anti-Australia Antigens,Anti-HBAg,Anti-Hepatitis B Antigens,Anti HBAg,Hepatitis B Virus Antibodies,Anti Australia Antigens,Anti Hepatitis B Antigens,Antibodies, Hepatitis B,Antigens, Anti-Australia,Antigens, Anti-Hepatitis B,B Antibodies, Hepatitis,B Antigens, Anti-Hepatitis,HBAg, Anti
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013789 Thalassemia A group of hereditary hemolytic anemias in which there is decreased synthesis of one or more hemoglobin polypeptide chains. There are several genetic types with clinical pictures ranging from barely detectable hematologic abnormality to severe and fatal anemia. Thalassemias
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations

Related Publications

S Leonardi, and P Barone, and S Musumeci
June 1995, JAMA,
S Leonardi, and P Barone, and S Musumeci
November 1993, The Pediatric infectious disease journal,
S Leonardi, and P Barone, and S Musumeci
June 1995, Lancet (London, England),
S Leonardi, and P Barone, and S Musumeci
June 1991, DICP : the annals of pharmacotherapy,
S Leonardi, and P Barone, and S Musumeci
June 1999, The Journal of infectious diseases,
S Leonardi, and P Barone, and S Musumeci
January 2021, Northern clinics of Istanbul,
S Leonardi, and P Barone, and S Musumeci
April 2007, Alimentary pharmacology & therapeutics,
S Leonardi, and P Barone, and S Musumeci
December 1986, Lancet (London, England),
S Leonardi, and P Barone, and S Musumeci
December 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
S Leonardi, and P Barone, and S Musumeci
August 1987, Journal of medical virology,
Copied contents to your clipboard!